Intestinal origin alkaline phosphatase activity (ALP) in plasma was measured by a sensitive immunocapture assay in 104 jaundiced patients-84 with intrahepatic and 20 with post-hepatic jaundice. Increased enzyme activities were observed in those with intrahepatic disease and subnormal values in those with post-hepatic disease. At a discriminant level intestinal origin ALP showed a diagnostic sensitivity of 77% for intrahepatic cholestasis, with a diagnostic accuracy of 75% for its differentiation from post-hepatic jaundice. This diagnostic accuracy is not as good as that derived with other techniques -for example, imaging-and the technique is therefore not recommended as a supplement or replacement.
Intestinal origin alkaline phosphatase (ALP; EC 3.1.3.1) may be increased in plasma in intrahepatic disease, but is unusual in posthepatic cholestasis.'' Using polyacrylamide gel electrophoresis, Warnes, Hine, and Kay found intestinal (fl-globulin mobility) ALP in the plasma of 45% of jaundiced patients with intrahepatic disease, but not in those with post-hepatic lesions. 4 They suggested that in jaundiced patients its presence was indicative of an intra-hepatic aetiology and was a useful differential diagnostic aid. They did not, however, study the effect of blood group, a factor that is known to affect the activity of this isoenzyme. 7 Studies from our laboratory, using both polyacrylamide gel and cellulose acetate membrane electrophoresis, indicated poor diagnostic sensitivity of intestinal ALP for intrahepatic jaundice, especially in patients not of blood group 0, and incomplete specificity for post-hepatic disease, so that overall efficiency for the differentiation of jaundice was poor.8 This poor differentiation by these qualitative procedures was supported by quantitative studies of activity remaining after inhibition of p-bromotetramisole.' These showed substantial overlap in intestinal origin ALP activity between the two diagnostic groups.
The development of more sensitive measurements of intestinal origin ALP activity by immunoassay has increased interest in possible differences between the two forms of jaundice. Using such an assay, Domar et al noted a pronounced increase in intestinal origin ALP in patients with nonbiliary or primary biliary cirrhosis but no increase in patients with other causes of cholestasis.9 The numbers studied were small, however, and again blood group was not considered.
In addition to high analytical sensitivity, immunological measurement of intestinal origin ALP has the advantage of measuring both intestinal (fl-electrophoretic mobility) ALP We therefore re-evaluated the measurement of intestinal origin ALP in the plasma for the differentiation of intra-and post-hepatic jaundice using a highly specific and sensitive immunoassay" that reacts with both intestinal and intestinal variant fractions, which together comprise intestinal origin ALP in plasma.
Methods
Non-fasting plasma samples were studied from 104 consecutive patients admitted to a specialist liver unit, with total bilirubin greater than 50 ,umol/l: 84 had intrahepatic and 20 posthepatic jaundice. Diagnosis (table 1) was based on clinical findings, together with liver function and serological tests either alone (n = 17) or supplemented by ultrasonography (n = 46), radiological examination (n = 65), or liver histology (n = 51). Samples were also obtained from 61 healthy volunteer medical students. Plasma samples were stored at -18°C and examined within two months of collection. All samples were ABO blood grouped by reverse grouping.
Intestinal origin ALP in plasma was quantified by a microtitre plate immunocapture assay, as described previously." The assay was linear up to 20 IU/l (IFCC method at 37GC)" and samples with activities above this range were appropriately diluted. Interbatch (n = 13) imprecision (CV) was 8-6% at a mean activity of 1-9 IU/1. The detection limit for intestinal origin ALP was 0-2 IU/1.
Results
The distribution of intestinal origin ALP values in both patients and students was nonGaussian (figure). Median activities in the patients for all blood groups considered 
Discussion
Our findings confirm the finding ofhigher intestinal origin ALP in plasma in healthy subjects and in patients with liver disease ofblood group O compared with blood group A.'7 With such differences taken into account, increased intestinal origin ALP was seen in plasma in intrahepatic jaundice and reduced activity in posthepatic disease. This agrees with a previous suggestion that post-hepatic biliary obstruction may interfere with the absorption of intestinal ALP; hepatocyte damage may decrease its plasma clearance. '4 To assess the diagnostic value of the measurement we first considered activity in relation to the relevant blood group upper reference limit, 12 IU/l for blood group 0 and 2 IU/I for group A, respectively. Intestinal origin alkaline phosphatase activity in plasmafor differential diagnosis ofjaundice obtained using a quantitative immunoassay of excellent analytical performance further improvement of diagnostic accuracy is unlikely.
In conclusion, an overall diagnostic accuracy of (at best) 75% was obtained by a specific and sensitive measurement of intestinal origin ALP. As this method remains inferior to accuracies close to 90% that can be obtained with other techniques used for the differential diagnosis of jaundice such as ultrasonography, computed tomography, and liver biopsy,'5 we do not recommend that these procedures be replaced or supplemented by the measurement.
